SCHEMBL719936

SCHEMBL719936

NCC(O)CN1CCN(CC(O)CN)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
KDM4E B2RXH2 2/20 0.52
USP2 O75604 4/20 0.48
ATM Q13315 2/20 0.48
MAPT P10636 1/20 0.48
HSD17B10 Q99714 1/20 0.43
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
GLA P06280 1/20 0.37
TSHR P16473 1/20 0.37
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL488658 0.90 MEN1 (0.68) MEN1KMT2AKDM4EUSP2ATM
SCHEMBL5241239 0.90 MEN1 (0.68) MEN1KMT2AKDM4EUSP2ATM
SCHEMBL488845 0.90 MEN1 (0.68) MEN1KMT2AKDM4EUSP2ATM
SCHEMBL689191 0.89 KDM4E (0.51) MEN1KMT2AKDM4EUSP2ATM
SCHEMBL11218218 0.89 ALOX15 (0.56) MEN1KMT2AKDM4EUSP2ATM
SCHEMBL10321382 0.89 KDM4E (0.51) MEN1KMT2AKDM4EUSP2ATM
SCHEMBL10320703 0.89 KDM4E (0.51) MEN1KMT2AKDM4EUSP2ATM
Ammonia Solution, Strong SCHEMBL488859 0.87 MEN1 (0.65) MEN1KMT2AKDM4EUSP2ATM
SCHEMBL5241128 0.87 MEN1 (0.73) MEN1KMT2AKDM4EUSP2ATM
SCHEMBL5243196 0.87 MEN1 (0.73) MEN1KMT2AKDM4EUSP2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2604255-B1 Novel reagents for transfection of eukaryotic cells MOLECULAR TRANSFER INC (US) 2017-10-25 EP disclosed
US-8759499-B2 Lipids for transfection of Eukaryotic cells MOLECULAR TRANSFER, INC. (US) 2014-06-24 US disclosed
EP-2604255-A1 Novel reagents for transfection of eukaryotic cells Molecular Transfer, Inc. (US) 2013-06-19 EP disclosed
EP-2015780-B1 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS MOLECULAR TRANSFER INC (US) 2012-12-12 EP disclosed
US-20120052574-A1 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS MOLECULAR TRANSFER, INC. (US) 2012-03-01 US disclosed
US-7915230-B2 Reagents for transfection of eukaryotic cells MOLECULAR TRANSFER, INC. (US) 2011-03-29 US disclosed
US-20090023215-A1 Novel reagents for transfection of eukaryotic cells MOLECULAR TRANSFER (US) 2009-01-22 US disclosed
EP-2015780-A2 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS Molecular Transfer, Inc. (US) 2009-01-21 EP disclosed
WO-2007130073-A2 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS MOLECULAR TRANSFER, INC. (US) 2007-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023215-A1 Novel reagents for transfection of eukaryotic cells FUS, PHAX, PICALM MEN1 1559/4885KMT2A 4019/4885KDM4E 4645/4885
US-20120052574-A1 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS FUS, PHAX, PICALM MEN1 1559/4885KMT2A 4019/4885KDM4E 4645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.